Physician profile

Ahmad Y Alshash

Allergy & Immunology · West Des Moines, IA

NPI 1881607786

$872.43

in general payments reported to CMS, 2019-2025

16 companies · none reported in 2025

See the full distribution for Allergy & Immunology

Payments by year

General payments by program year, as reported to CMS.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Shire North American Group INC $223.61 2019
Astrazeneca Pharmaceuticals LP $138.57 2019-2020
Pharming Healthcare, INC. $119.61 2019
Glaxosmithkline, LLC. $72.50 2019-2020
Jubilant Hollisterstier LLC $56.51 2019
Genzyme Corporation $45.94 2019
Novartis Pharmaceuticals Corporation $39.25 2019
Sunovion Pharmaceuticals INC. $38.80 2019
Circassia INC. $25.37 2019-2020
Grifols USA, LLC $25.03 2019
Regeneron Healthcare Solutions, INC. $24.66 2019
Teva Pharmaceuticals USA, INC. $13.67 2019
Kaleo, INC. $13.18 2019
Phadia US INC. $12.17 2019
Boehringer Ingelheim Pharmaceuticals, INC. $11.78 2019
Show all 16 companies
CompanyGeneral paymentsYearsTop products
Takeda Pharmaceuticals U.S.A., INC. $11.78 2021

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Ahmad Y Alshash

$872.43

in general payments reported 2019-2025

Years
2019-2021
Top company
Shire North American Group INC

https://glasscript.com/doctor/85284/ahmad-y-alshash

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.